Nov 5, 2014
Blueprint for new IITs and NITs likely to roll out today
read more...
AUSIB promotes High Profile Higher Education Events, Business Events, Trade and Investments between The United States and India
Oct 28, 2014
India Projected to Become Third-biggest Aviation Market by 2031
read more...
AUSIB promotes High Profile Higher Education Events, Business Events, Trade and Investments between The United States and India
Oct 8, 2014
IMF issues warning on slower economic growth in 2014 and 2015
read more...
AUSIB promotes High Profile Higher Education Events, Business Events, Trade and Investments between The United States and India
Oct 8, 2014
USINPAC releases #US-#India ‘Business Barometer’
read more...
AUSIB promotes High Profile Higher Education Events, Business Events, Trade and Investments between The United States and India
Oct 8, 2014
More than half of U.S. unlikely to do business in India: study
read more...
AUSIB promotes High Profile Higher Education Events, Business Events, Trade and Investments between The United States and India
Oct 8, 2014
More than half of US unlikely to do business in India: Reports
read more...
AUSIB promotes High Profile Higher Education Events, Business Events, Trade and Investments between The United States and India
Oct 8, 2014
US lawmakers forge ahead to set US-India relations on new course
read more...
AUSIB promotes High Profile Higher Education Events, Business Events, Trade and Investments between The United States and India
Oct 6, 2014
New MoU to be signed between India and the USA gets nod from the Indian Cabinet
read more...
AUSIB promotes High Profile Higher Education Events, Business Events, Trade and Investments between The United States and India
Sep 30, 2014
India set to become a founding partner in the Thirty Meter Telescope Project in Pacific Ocean
read more...
AUSIB promotes High Profile Higher Education Events, Business Events, Trade and Investments between The United States and India
Sep 30, 2014
Global Initiative of Academic Networks approved by the Indian HRD Ministry
read more...
AUSIB promotes High Profile Higher Education Events, Business Events, Trade and Investments between The United States and India
Sep 23, 2014
Narendra Modi will build new IIT in Goa aided by US institutions
read more...
AUSIB promotes High Profile Higher Education Events, Business Events, Trade and Investments between The United States and India
Aug 28, 2014
Turning Point in Bilateral Relations: US Medical Delegation to India arrives
read more...
AUSIB promotes High Profile Higher Education Events, Business Events, Trade and Investments between The United States and India
Aug 26, 2014
Indian American author Nina McConigley wins PEN Open Book Award
read more...
AUSIB promotes High Profile Higher Education Events, Business Events, Trade and Investments between The United States and India
Aug 26, 2014
Indian-American educator Pradeep Khosla to help India with hospital management
read more...
AUSIB promotes High Profile Higher Education Events, Business Events, Trade and Investments between The United States and India
Aug 26, 2014
India-US natural partners: US diplomat
read more...
AUSIB promotes High Profile Higher Education Events, Business Events, Trade and Investments between The United States and India
View All

Kiran Mazumdar-Shaw's Biocon develops new breast cancer drug

Source : TIMES OF INDIA
Jan 21, 2014

 BANGALORE: Biopharmaceutical major Biocon has launched a new injectable drug for the treatment of a highly prevalent form of breast cancer and has priced its product 25 per cent lower than existing drugs in the market.

After cervical cancer, breast cancer is the most common form of cancer among Indian women, with 1.5 lakh new patients being diagnosed with the disease every year. Of that, nearly 25 per cent are diagnosed with a particular type of breast cancer known as HER2-positive breast cancer.

This type of breast cancer is said to be the most aggressive and fast growing, having a much higher risk of early recurrence and death. Biocon's new drug, called
CANMAb and priced at Rs 57,500 for a 440 mg vial and Rs 19,500 for a 150 mg vial, has been developed for the treatment of HER2-positive breast cancer.

The drug has been jointly developed by Biocon and US-based generic pharmaceutical major Mylan and is expected to hit the Indian market in early February. The drug will be manufactured in Biocon's facility in Bangalore.

CANMAb will compete with Herceptin, an existing drug priced at Rs 75,000 for a 440 mg vial, which is also the innovator (original) product for the treatment of HER2- breast cancer developed by Swiss pharma company
Roche. The global sales for Herceptin stood at $6.4 billion in 2012; in India it was $21 million.

"Biocon intends to make a significant difference in the treatment paradigm for
HER2-positive breast cancer in India by enhancing access to more affordable treatment with CANMAb, which offers the same level of safety and efficacy as the reference product (Herceptin)," said Kiran Mazumdar-Shaw, CMD, Biocon.


  • AUSIB joins Nagpur First as Supporting Partners for Annual Global Nagpur Summit 2015
    read more...
  • Events and Delegations between India and The United States
  • Edwin Burkett
  • James mancuso
  • Gerald V quinnan
  • Mark evans
  • Rahul jindal
  • Rahul jindal
^ Back to Top